NTLA-2001
Intellia Therapeutics
['cardio', 'crispr']
sustained, &gt;90% reduction of ttr by crispr-cas9 w no severe aes, promising first-in-human data! #cardiotwitter #aha22 
Cardiologist/Cardio-Oncologist & Immunologist. Director of Cardio-Oncology @AscensionSeton, Director @SetonHeartNW. Leader, Innovator & Educator #aging #cancer